Evidence map›Paper›PMID 37944820›Full record

ArticleTransplantation and cellular therapy2024

Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.

Ke Zeng, Ryan Brewster, Joyce B Kang, Ekaterina Tkachenko, Erin Brooks, Ami S Bhatt, Anthony A Fodor, Tessa M Andermann

Open access · greenAbstract read
In one paragraph

Article in Transplantation and cellular therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Ke ZengDepartment of Bioinformatics and Genomics University of North Carolina at Charlotte Charlotte, North Carolina.
Ryan BrewsterDepartment of Pediatrics Boston Children's Hospital Boston, Massachusetts.
Joyce B KangSchool of Medicine Harvard Boston, Massachusetts.
Ekaterina TkachenkoSchool of Medicine Stanford University Stanford, California.
Erin BrooksDepartment of Medicine Division of Hematology Stanford University, Stanford, California.
Ami S BhattDepartment of Genetics, Stanford University, Stanford, California; Department of Medicine, Division of Blood and Marrow Transplantation, Stanford University, Stanford, California.
Anthony A FodorDepartment of Bioinformatics and Genomics University of North Carolina at Charlotte Charlotte, North Carolina.
Tessa M AndermannDepartment of Medicine Division of Infectious Diseases University of North Carolina at Chapel Hill Chapel Hill, North Carolina. Electronic address: tessa_andermann@med.unc.edu.
Stanford University · USUniversity of North Carolina at Charlotte · USBoston Children's Hospital · USHarvard University · USStanford Blood Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
Precision characterization of antimicrobial resistance gene dynamics in bloodstream infection risk after hematopoietic stem cell transplantationK23AI163365 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ANDERMANN, TESSA · 2021 to 2025
$1.0M
Sequence-based pathogen discovery in post-stem cell transplantation syndromesK08CA184420 · NCI · STANFORD UNIVERSITY · PI BHATT, AMI SIDDHARTH · 2014 to 2017
$524k
NCI NIH HHS K08 CA184420NIAID NIH HHS K23 AI163365NIGMS NIH HHS T32 GM144273
6 · The paper itself

Abstract

Taxonomic composition of the gut microbiota at the time of neutrophil engraftment is associated with the development of acute gastrointestinal graft-versus-host disease (GI GVHD) in patients undergoing allogeneic hematopoietic stem cell transplantation. However, less is known about the relationship between the gut microbiota and development of steroid-refractory GI GVHD immediately before the onset of disease. Markers of steroid-refractory GI GVHD are needed to identify patients who may benefit from the early initiation of non-corticosteroid-based GVHD treatment. Our aim was to identify differences in taxonomic composition in stool samples from patients without GVHD, with steroid-responsive GVHD and with steroid-refractory GI GVHD to identify predictive microbiome biomarkers of steroid-refractory GI GVHD. We conducted a retrospective case-control, single institution study, performing shotgun metagenomic sequencing on stool samples from patients with (n = 36) and without GVHD (n = 34) matched for time since transplantation. We compared the taxonomic composition of the gut microbiome in those with steroid-sensitive GI GVHD (n = 17) and steroid-refractory GI GVHD (n = 19) to each other and to those without GVHD. We also performed associations between steroid-refractory GI GVHD, gut taxonomic composition, and fecal calprotectin, a marker of GI GVHD to develop composite fecal markers of steroid-refractory GVHD before the onset of GI disease. We found that fecal samples within 30 days of GVHD onset from patients with and without GVHD or with and without steroid-refractory GI GVHD did not differ significantly in Shannon diversity (alpha-diversity) or in overall taxonomic composition (beta-diversity). Although those patients without GVHD had higher relative abundance of Clostridium spp., those with and without steroid-refractory GI GVHD did not significantly differ in taxonomic composition between one another. In our study, fecal calprotectin before disease onset was significantly higher in patients with GVHD compared to those without GVHD and higher in patients with steroid-refractory GI GVHD compared to steroid-sensitive GI GVHD. No taxa were significantly associated with higher levels of calprotectin.

Indexed as

Gastrointestinal TractGraft vs Host DiseaseHumansLeukocyte L1 Antigen ComplexRetrospective StudiesSteroidsLeukocyte L1 Antigen ComplexSteroidsBlood and marrow transplantGraft-versus-host diseaseHematopoietic stem cell transplantationMicrobiomeMicrobiotaSteroid-refractory GVHD

Identifiers

PMID37944820
PMCPMC10872415
OpenAlexW4388450540

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.